Soluble PD-1 and PD-L1 as potential biomarkers for classical Hodgkin lymphoma

被引：11

作者：

da Silva, Priscilla Brito ^{[1
]}

Real, Juliana Monte ^{[2
,3
,4
]}

Pinto Ferreira, Ludmila Rodrigues ^{[5
]}

Esteves, Gustavo H. ^{[6
]}

Brito, Fabio do Nascimento ^{[1
]}

Baiocchi, Otavio C. G. ^{[1
,7
]}

机构：

[1] Univ Fed Sao Paulo, UNIFESP, Dept Oncol Clin & Expt, Sao Paulo, Brazil

[2] Inst Canc Estado Sao Paulo, Ctr Invest Translac Oncol, Sao Paulo, Brazil

[3] Hosp Serv Publ Estadual Sao Paulo, IAMSPE, Sao Paulo, Brazil

[4] Hosp Santa Marcelina, Assoc TUCCA Criancas & Adolescentes Com Canc, Dept Oncol Pediat, Sao Paulo, Brazil

[5] Univ Fed Minas Gerais, ICB UFGM, Inst Ciencias Biol, Dept Morphol, Belo Horizonte, MG, Brazil

[6] Univ Estadual Paraiba, UEPB, Dept Estat, Campina Grande, Brazil

[7] HAOC, Hematol Div, Sao Paulo, Brazil

来源：

HEMATOLOGICAL ONCOLOGY | 2018年 / 36卷 / 04期

基金：

巴西圣保罗研究基金会;

关键词：

DEATH-LIGAND; 1; MICROENVIRONMENT; EXPRESSION;

D O I：

10.1002/hon.2542

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：709 / 712

页数：4

共 50 条

[41] A snapshot of the PD-1/PD-L1 pathway
Ghosh, Chinmoy
Luong, Gary
Sun, Yue
JOURNAL OF CANCER, 2021, 12 (09): : 2735 - 2746
[42] PD-1/PD-L1 in cardiovascular disease
Sun, YunFeng
Li, Liang
Wu, YaWei
Yang, KePing
CLINICA CHIMICA ACTA, 2020, 505 : 26 - 30
[43] PD-1 and PD-L1 antibodies for melanoma
Tsai, Katy K.
Zarzoso, Ines
Daud, Adil I.
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (11) : 3111 - 3116
[44] Expression regulation and function of PD-1 and PD-L1 in T lymphoma cells
Liu, Maria Y.
Klement, John D.
Langan, Candace J.
Riggelen, Jan van
Liu, Kebin
CELLULAR IMMUNOLOGY, 2021, 366
[45] PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome
Roemer, Margaretha G. M.
Advani, Ranjana H.
Ligon, Azra H.
Natkunam, Yasodha
Redd, Robert A.
Homer, Heather
Connelly, Courtney F.
Sun, Heather H.
Daadi, Sarah E.
Freeman, Gordon J.
Armand, Philippe
Chapuy, Bjoern
de Jong, Daphne
Hoppe, Richard T.
Neuberg, Donna S.
Rodig, Scott J.
Shipp, Margaret A.
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (23) : 2690 - +
[46] PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome
Roemer, Margaretha G. M.
Advani, Ranjana H.
Ligon, Azra H.
Natkunam, Yasodha
Redd, Robert A.
Homer, Heather
Connelly, Courtney
Sun, Heather H.
Daadi, Sarah E.
Chapuy, Bjoern
de Jong, Daphne
Hoppe, Richard T.
Neuberg, Donna S.
Rodig, Scott J.
Shipp, Margaret A.
BLOOD, 2015, 126 (23)
[47] Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signaling
Annika De Sousa Linhares
Claire Battin
Sabrina Jutz
Judith Leitner
Christine Hafner
Joshua Tobias
Ursula Wiedermann
Michael Kundi
Gerhard J. Zlabinger
Katharina Grabmeier-Pfistershammer
Peter Steinberger
Scientific Reports, 9
[48] SERUMAND URINARY SOLUBLE PD-1, PD-L1 AND PD-L2 AS BIOMARKERS FOR CHECKPOINT INHIBITOR RELATED ACUTE INTERSTITIAL NEPHRITIS
Gomez-Preciado, Francisco
Martinez Valenzuela, Laura
Anton Pampols, Paula
Gomez-Tena, Marina
Goma, Montserrat
Rau Lertora, Ana Melissa
Rubio Rodriguez, Belen
Nadal, Ernest
Jove, Maria
Fulladosa Oliveras, Xavier
Cruzado, Josep
Torras Ambros, Joan
Draibe, Juliana
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I256 - I256
[49] Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signaling
Linhares, Annika De Sousa
Battin, Claire
Jutz, Sabrina
Leitner, Judith
Hafner, Christine
Tobias, Joshua
Wiedermann, Ursula
Kundi, Michael
Zlabinger, Gerhard J.
Grabmeier-Pfistershammer, Katharina
Steinberger, Peter
SCIENTIFIC REPORTS, 2019, 9 (1)
[50] Relevance of host and tumor PD-L1 expression in PD-L1 and PD-1 blockade
Lin, Heng
Wei, Shuang
Vatan, Linda
Kryczek, Ilona
Zou, Weiping
JOURNAL OF IMMUNOLOGY, 2017, 198 (01):

← 1 2 3 4 5 →